Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergey Trushin

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Acta Pharmaceutica Sinica. B|March 8, 2022
Mitochondrial complex I as a therapeutic target for Alzheimer's diseaseEugenia Trushina, Sergey Trushin, Md Fayad Hasan
Biorxiv : the Preprint Server for Biology|June 4, 2026
A Small-Molecule Mitochondrial Complex I Modulator Improves Behavioral and Mitochondrial Dysfunction in SchizophreniaMaltesh Kambali, Sergey Trushin, Muxiao Wang, et al.
Mitochondrion|February 21, 2021
A genome-wide association study in human lymphoblastoid cells supports safety of mitochondrial complex I inhibitorHuanyao Gao, Utkarsh Tripathi, Sergey Trushin, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Discovery and Preclinical Validation of a Clinically Optimized Mitochondrial Complex I Modulator for Alzheimer's DiseaseSergey Trushin, Thi Kim Oanh Nguyen, Mark Ostroot, et al.
Cells|May 16, 2023
Partial Inhibition of Complex I Restores Mitochondrial Morphology and Mitochondria-ER Communication in Hippocampus of APP/PS1 MiceJessica Panes, Thi Kim Oanh Nguyen, Huanyao Gao, et al.
Neurobiology of Disease|February 26, 2018
Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membraneLiang Zhang, Sergey Trushin, Trace A Christensen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 30, 2025
Mitochondrial complex I deficiency induces Alzheimer's disease-like signatures that are reversible by targeted therapyHuanyao Gao, Kate Jensen, Jarred Nesbitt, et al.
Ebiomedicine|September 16, 2025
Therapeutic assessment of a novel mitochondrial complex I inhibitor in in vitro and in vivo models of Alzheimer's diseaseSergey Trushin, Thi Kim Oanh Nguyen, Andrea Stojakovic, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Therapeutic assessment of a novel mitochondrial complex I inhibitor in <i>in vitro</i> and <i>in vivo</i> models of Alzheimer's diseaseSergey Trushin, Thi Kim Oanh Nguyen, Andrea Stojacovic, et al.
The Journal of Biological Chemistry|August 24, 2011
Isolation of a TRAIL antagonist from the serum of HIV-infected patientsDavid J Schnepple, Brett Shepard, Gary D Bren, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Acta Pharmaceutica Sinica. B|March 8, 2022
Mitochondrial complex I as a therapeutic target for Alzheimer's diseaseEugenia Trushina, Sergey Trushin, Md Fayad Hasan
Biorxiv : the Preprint Server for Biology|June 4, 2026
A Small-Molecule Mitochondrial Complex I Modulator Improves Behavioral and Mitochondrial Dysfunction in SchizophreniaMaltesh Kambali, Sergey Trushin, Muxiao Wang, et al.
Mitochondrion|February 21, 2021
A genome-wide association study in human lymphoblastoid cells supports safety of mitochondrial complex I inhibitorHuanyao Gao, Utkarsh Tripathi, Sergey Trushin, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Discovery and Preclinical Validation of a Clinically Optimized Mitochondrial Complex I Modulator for Alzheimer's DiseaseSergey Trushin, Thi Kim Oanh Nguyen, Mark Ostroot, et al.
Cells|May 16, 2023
Partial Inhibition of Complex I Restores Mitochondrial Morphology and Mitochondria-ER Communication in Hippocampus of APP/PS1 MiceJessica Panes, Thi Kim Oanh Nguyen, Huanyao Gao, et al.
Neurobiology of Disease|February 26, 2018
Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membraneLiang Zhang, Sergey Trushin, Trace A Christensen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 30, 2025
Mitochondrial complex I deficiency induces Alzheimer's disease-like signatures that are reversible by targeted therapyHuanyao Gao, Kate Jensen, Jarred Nesbitt, et al.
Ebiomedicine|September 16, 2025
Therapeutic assessment of a novel mitochondrial complex I inhibitor in in vitro and in vivo models of Alzheimer's diseaseSergey Trushin, Thi Kim Oanh Nguyen, Andrea Stojakovic, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Therapeutic assessment of a novel mitochondrial complex I inhibitor in <i>in vitro</i> and <i>in vivo</i> models of Alzheimer's diseaseSergey Trushin, Thi Kim Oanh Nguyen, Andrea Stojacovic, et al.
The Journal of Biological Chemistry|August 24, 2011
Isolation of a TRAIL antagonist from the serum of HIV-infected patientsDavid J Schnepple, Brett Shepard, Gary D Bren, et al.
Pageof 2